Infectious Diseases Practice Questions

Q: What is the most common source of Diphtheria?

Carrier. ***Carrier*** - **Carriers** (asymptomatic individuals harboring *Corynebacterium diphtheriae*) are the **most common source** of diphtheria transmission. - Carriers outnumber symptomatic cases by a **ratio of 10:1 or more** in the community. - They shed bacteria through **respiratory droplets for weeks to months** without showing symptoms, making them difficult to identify and isolate. - Carriers form the **primary reservoir** that maintains diphtheria transmission in populations, especially in areas with suboptimal immunization coverage. - This is a fundamental epidemiological principle emphasized in Community Medicine. *Infected individual* - While symptomatic infected individuals do transmit diphtheria, they are **less common** as a source compared to carriers. - Symptomatic cases are more likely to be **identified, isolated, and treated** quickly, limiting their transmission potential. - They represent the "tip of the iceberg" in diphtheria epidemiology. *Infected environment* - *Corynebacterium diphtheriae* does not survive for extended periods outside the human host. - Environmental transmission is **extremely rare** and not a significant mode of spread. - Diphtheria is primarily transmitted through **respiratory droplets** (person-to-person contact). *None of the options* - Incorrect, as **carrier** is clearly the most common source of diphtheria.

Q: What type of approach does the colored kit for STD treatment represent?

Syndromic. ***Syndromic*** - A **syndromic approach** to STD treatment involves managing patients based on the **symptoms** they present, rather than waiting for laboratory confirmation of specific pathogens. - The colored kit likely provides a pre-packaged set of medications to treat the most common causes of a particular STD syndrome, allowing for rapid and effective treatment without relying on complex diagnostics. *Preventive* - **Preventive approaches** aim to avert the occurrence of disease through measures like **vaccination**, safe sex education, and condom distribution. - While treating STDs has a secondary preventive effect by reducing transmission, the colored kit itself is a treatment tool, not primarily a preventive measure. *Symptomatic* - While the syndromic approach *uses* symptoms, the term **symptomatic** treatment typically refers to relieving symptoms without necessarily addressing the underlying cause or making a specific diagnosis. - The colored kit aims to treat the suspected *cause* of the syndrome, not just palliate symptoms, distinguishing it from purely symptomatic management. *Rehabilitative* - **Rehabilitative approaches** focus on restoring function and quality of life after an illness or injury, often involving therapies and long-term care. - STD treatment is acute and aims to cure the infection, which is distinctly different from rehabilitation.

Q: What was the color of the box containing drugs for the treatment of Category I tuberculosis (TB) under the DOTS program?

Yellow. ***Yellow*** - The **yellow box** was designated for **Category I TB drugs** under the **DOTS (Directly Observed Treatment, Short-course)** strategy. - Category I treated **newly diagnosed sputum smear-positive pulmonary TB**, severely ill smear-negative cases, and severe extrapulmonary TB. - **Note:** India transitioned from category-based to **weight-based TB treatment** in 2012 under NTEP (formerly RNTCP). This color-coded system is now historical. *Red* - The **red box** was used for **Category II TB treatment**, covering **retreatment cases** (relapse, treatment failure, or treatment after default). - These regimens included additional drugs like streptomycin with different durations compared to Category I. *Blue* - The **blue box** was used for **Category III TB treatment** in the DOTS program. - Category III covered new smear-negative pulmonary TB cases and less severe extrapulmonary TB. *Green* - The **green box** was not part of the standard category-based DOTS framework for TB drug distribution. - The three main categories used yellow, red, and blue color-coding to prevent dispensing errors.

Q: What is the primary purpose of taking sewer swabs in public health?

Typhoid carriers in the community. ***Typhoid carriers in the community*** - Sewer swabs are primarily used to detect the presence of **Salmonella Typhi** in sewage, indicating the presence of **asymptomatic carriers** shedding the bacteria. - This method helps identify populations where **typhoid fever** may silently spread or persist due to chronic carriers. *Active typhoid cases in the community* - While sewer swabs can indirectly indicate **active cases** due to increased shedding, their primary purpose is to identify **carriers** who might not be exhibiting symptoms. - **Clinical diagnosis** and **stool culture** from symptomatic individuals are more direct methods for identifying active typhoid cases. *Active cholera cases in the community* - Sewer swabs *can* detect **Vibrio cholerae**, the bacterium causing cholera, but this is not their primary use, especially when targeting **typhoid surveillance**. - **Cholera** outbreaks typically prompt targeted **water sample testing** and clinical surveillance due to their rapid onset and severity. *Cholera carriers in the community* - Similar to active cases, while possible to detect **Vibrio cholerae**, sewer swabs are not the primary tool specifically for identifying **cholera carriers**. - **Cholera carriers** are less common and their detection is usually part of broader environmental surveillance during or after an outbreak.

Q: Post exposure prophylaxis is not indicated in which of the following conditions?

Typhoid. ***Typhoid*** - **Post-exposure prophylaxis (PEP)** is generally **not indicated** for typhoid fever, as **antibiotic treatment** is highly effective once symptoms develop. - Prevention primarily involves **vaccination** and ensuring **safe food and water hygiene**, not medication after exposure. *Rabies* - **PEP is crucial** for rabies due to its nearly 100% fatality rate once symptoms appear, involving **vaccine** and **immunoglobulin** administration. - Exposure typically occurs through bites or scratches from **rabid animals**. *Chickenpox* - **PEP** with **VariZIG (varicella zoster immune globulin)** or **antiviral medications** may be indicated for high-risk individuals after exposure. - This is primarily to prevent severe disease in **immunocompromised individuals** or pregnant women without immunity. *Measles* - **PEP** with the **measles vaccine** or **immunoglobulin (IG)** is recommended for susceptible individuals exposed to measles. - This intervention can **prevent or modify the course** of the disease, especially in unvaccinated contacts.

Q: Which of the following statements about measles is false?

Infectivity is low. ***Infectivity is low*** - Measles is highly contagious, with an **R0 (basic reproduction number)** typically between 12 and 18, making it one of the most infectious human diseases. - Its high infectivity is why **herd immunity** requires a very high vaccination coverage rate (around 95%) to prevent outbreaks. *Koplik's spots is pathognomonic* - **Koplik's spots** are indeed considered **pathognomonic** for measles, appearing as small, white, bluish-white, or grayish lesions on the buccal mucosa opposite the molars. - These spots typically emerge 2-3 days before the characteristic rash and fade as the rash develops. *Measles commonly affects individuals of any age who are not immune.* - Lack of immunity, either through vaccination or previous infection, makes an individual susceptible to measles **regardless of age**. - In developed countries, outbreaks often occur in unvaccinated populations or those with waning immunity, as seen in adults who may not have received measles vaccines or caught the infection as children. *The source of infection is typically an infected person* - Measles is an **airborne disease** spread through respiratory droplets from an infected person's coughing and sneezing. - The virus can live for up to two hours in the air or on surfaces, making direct contact with an infected individual or their respiratory secretions the primary mode of transmission.

Q: According to RNTCP guidelines, what should be done first in a TB suspect case?

Sputum microscopy. ***Sputum microscopy*** - Under the Revised National Tuberculosis Control Programme (RNTCP) guidelines, **sputum smear microscopy** is the initial and primary diagnostic tool for identifying pulmonary TB in suspect cases. - It is a **cost-effective and rapid method** for detecting **acid-fast bacilli (AFB)** directly from sputum samples. *Chest X-ray* - While a Chest X-ray can show abnormalities consistent with TB, it is often used as a **supplementary diagnostic tool** after initial sputum tests. - It is **less specific** than sputum microscopy for confirming active TB and requires further confirmation with microbiological tests. *Sputum culture* - Sputum culture is a **more sensitive diagnostic method** for TB compared to microscopy, but it takes **several weeks** for results. - It is typically used when smear microscopy results are negative but there is a strong clinical suspicion of TB, or for **drug susceptibility testing**. *Start short-course chemotherapy* - Initiating short-course chemotherapy **without confirming the diagnosis** is not recommended and can lead to antibiotic resistance and inappropriate treatment. - Treatment should only be started after a **confirmed diagnosis** of active TB through microbiological tests like sputum microscopy or culture.

Q: What is the primary causative vector of Vagabond disease?

Louse. ***Louse*** - Vagabond disease is a term historically used to describe the chronic skin changes (such as **pigmentation**, **lichenification**, and **excoriations**) resulting from persistent **pediculosis corporis** (body lice infestation). - The **body louse** (*Pediculus humanus corporis*) is the causative agent responsible for these chronic dermatological changes through prolonged infestation. - Body lice are also vectors that can transmit other diseases like **epidemic typhus**, **louse-borne relapsing fever**, and **trench fever**, but vagabond disease itself is the direct result of chronic louse infestation rather than a transmitted pathogen. *Mite* - Mites are responsible for various conditions, such as **scabies** (caused by *Sarcoptes scabiei*) and serve as vectors for **scrub typhus** (transmitted by chiggers, the larval form of trombiculid mites). - However, they are not associated with vagabond disease or the chronic dermatological changes caused by body lice. *Tick* - Ticks are known vectors for a wide range of diseases, including **Lyme disease**, **Rocky Mountain spotted fever**, **anaplasmosis**, and **babesiosis**. - These diseases are transmitted through the bite of infected ticks, which are distinct from the louse-related conditions associated with vagabond disease. *Black Fly* - Black flies (*Simulium* species) are vectors for **onchocerciasis** (river blindness), caused by the parasitic nematode *Onchocerca volvulus*. - While they can cause itchy bites and transmit significant disease, they are not involved in the chronic skin condition known as vagabond disease.

Q: Chronic carriers of typhoid shed bacilli for how long after cure?

More than 1 year after cure. ***More than 1 year after cure*** - A definition of a **chronic carrier** of *Salmonella Typhi (S. typhi)* is someone who excretes the bacteria in their feces or urine for **more than one year** after the acute illness. - This prolonged shedding is often associated with the presence of bacteria in the **gallbladder**, leading to intermittent fecal excretion. *1-3 weeks after cure* - This period typically represents the timeframe during which individuals are still considered **convalescent carriers** rather than chronic carriers. - Many patients continue to shed *S. typhi* for a few weeks post-treatment, but significant public health concern arises with more prolonged shedding. *3 weeks to 3 months after cure* - This timeframe is generally considered the period for **convalescent shedding**, where a significant number of individuals might still excrete *S. typhi*. - While concerning, it does not meet the established definition of a **chronic carrier**, which requires shedding for over a year. *3 months - 1 year after cure* - Individuals shedding *S. typhi* in their feces for this duration are at high risk of becoming **chronic carriers** or are in a prolonged state of convalescent carriage. - However, the official definition of a chronic carrier specifically requires shedding to persist **beyond one year**.

Q: A male patient diagnosed with tuberculosis took complete treatment. Sputum examination was done after the completion of the intensive and the continuation phases. It was found to be negative. What is the status of the patient?

Cured. ***Cured*** - A patient is declared **cured** if they have completed the full course of treatment and have achieved **two negative sputum smear results**, with one at the end of the intensive phase and another at the completion of the treatment [1]. - This indicates that the **infection has been eradicated**, and the patient is no longer infectious. *Treatment completed* - This status applies when a patient has **completed the full treatment course** but does not have documented sputum smear results that meet the criteria for "cured." - While treatment was completed, the **bacteriological status is not confirmed** in the same way as for a cured patient. *Lost to follow up* - This term describes a patient who was **enrolled in treatment but was interrupted** for a specific period (e.g., two consecutive months or more) and their outcome cannot be determined. - They **ceased to attend follow-up appointments** and their treatment completion or success is unknown. *Treatment failed* - This status is assigned when a patient remains **sputum smear-positive at the end of the intensive phase** or at the end of the treatment, or if they initially converted to negative but later became positive again [1]. - It signifies that the **treatment regimen was ineffective** in eradicating the infection.

Question 1

What is the most common source of Diphtheria?

Accepted Answer

Carrier

Answer

Infected environment

Answer

Infected individual

Answer

None of the options

Question 2

What type of approach does the colored kit for STD treatment represent?

Accepted Answer

Syndromic

Answer

Preventive

Answer

Symptomatic

Answer

Rehabilitative

Question 3

What was the color of the box containing drugs for the treatment of Category I tuberculosis (TB) under the DOTS program?

Accepted Answer

Yellow

Answer

Blue

Answer

Green

Answer

Red

Question 4

What is the primary purpose of taking sewer swabs in public health?

Accepted Answer

Typhoid carriers in the community

Answer

Active typhoid cases in the community

Answer

Active cholera cases in the community

Answer

Cholera carriers in the community

Question 5

Post exposure prophylaxis is not indicated in which of the following conditions?

Accepted Answer

Typhoid

Answer

Rabies

Answer

Chickenpox

Answer

Measles

Question 6

Which of the following statements about measles is false?

Accepted Answer

Infectivity is low

Answer

Measles commonly affects individuals of any age who are not immune.

Answer

Koplik's spots are pathognomonic

Answer

The source of infection is typically an infected person

Question 7

According to RNTCP guidelines, what should be done first in a TB suspect case?

Accepted Answer

Sputum microscopy

Answer

Chest X-ray

Answer

Sputum culture

Answer

Start short-course chemotherapy

Question 8

What is the primary causative vector of Vagabond disease?

Accepted Answer

Louse

Answer

Mite

Answer

Tick

Answer

Black Fly

Question 9

Chronic carriers of typhoid shed bacilli for how long after cure?

Accepted Answer

More than 1 year after cure

Answer

1-3 weeks after cure

Answer

3 weeks to 3 months after cure

Answer

3 months - 1 year after cure

Question 10

A male patient diagnosed with tuberculosis took complete treatment. Sputum examination was done after the completion of the intensive and the continuation phases. It was found to be negative. What is the status of the patient?

Accepted Answer

Cured

Answer

Treatment completed

Answer

Lost to follow up

Answer

Treatment failed

Infectious Diseases — MCQs

Infectious Diseases — MCQs

On this page

Practice by Chapter

Want unlimited practice?